Elena Vitalievna Bogdanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Vitalievna Bogdanova has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Alexeevich Kubanov
State Research Center of Dermatovenereology and Cosmetology
16 shared publications - Arfenya Eu. Karamova
State Research Center of Dermatovenereology and Cosmetology
3 shared publications - Vadim V. Chikin
State Research Center of Dermatovenereology and Cosmetology
3 shared publications Богданова Елена
ФГБУ "Государственный научный центр дерматовенерологии и косметологии" Минздрава России
2 shared publicationsБогданова Елена Витальевна
ФГБУ "ГНЦДК" Минздрава России
2 shared publicationsМелехина Л. Е.
ФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 102 (4) , 33-48
Clinical and epidemiological characteristics of patients with pemphigus in the Russian Federation (based on patient registry data)
BACKGROUND: Investigating the clinical epidemiology of pemphigus is essential for understanding patient characteristics, identifying their healthcare needs, and evaluating the quality of care. AIM: To describe the clinical and epidemiological characteristics of patients with pemphigus in the Russian Federation. METHODS: Data from a pemphigus patient registry were examined. Demographic characteristics, medical history, patient comorbidity profiles, clinical disease characteristics, and the frequency of diagnostic method utilization were analyzed. RESULTS: A total of 332 patients were included. Pemphigus vulgaris was diagnosed in 82.6% of patients, pemphigus erythematosus in 10.2%, pemphigus foliaceus in 2.4%, and other pemphigus subtypes in 1.8% (including paraneoplastic pemphigus in 1.2%). A female predominance was observed in all pemphigus subtypes except pemphigus foliaceus. The mean (± standard deviation) age at disease onset was 52,1 ± 15,3 years. The peak age of onset occurred in the 35- to 39-year age group for men and the 60- to 64-year age group for women. A diagnostic delay of one year or more after disease onset was observed in 31.8% of patients. The diagnosis was confirmed by histopathological examination in 84.2% of patients (with immunofluorescence methods in 41.3%) and by enzyme-linked immunosorbent assay in 15.8%. Lesion-related pain was reported by 76.3% of patients (including severe pain in 21.5%), and pruritus was reported by 60.6% (including severe pruritus in 9.9%). Infectious complications were observed in 63.5% of patients. Comorbidities included hypertension (34.0%), chronic gastritis (19.3%), coronary artery disease (10.7%), diabetes mellitus (10.2%), thyroid disorders (9.9%), and chronic pancreatitis (8.4%). A history of malignancy was present in 6,4% of patients with non-paraneoplastic pemphigus. CONCLUSION: Pemphigus vulgaris and pemphigus erythematosus are the most common pemphigus subtypes in the Russian Federation. Men tend to experience an earlier age at disease onset. Further research is needed to investigate the causes of diagnostic delays in pemphigus and the underdiagnosis of paraneoplastic pemphigus.
- 28 September 2026
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 102 (4) , 33-48
Open AccessClinical and epidemiological characteristics of patients with pemphigus in the Russian Federation (based on patient registry data)
BACKGROUND: Investigating the clinical epidemiology of pemphigus is essential for understanding patient characteristics, identifying their healthcare needs, and evaluating the quality of care. AIM: To describe the clinical and epidemiological characteristics of patients with pemphigus in the Russian Federation. METHODS: Data from a pemphigus patient registry were examined. Demographic characteristics, medical history, patient comorbidity profiles, clinical disease characteristics, and the frequency of diagnostic method utilization were analyzed. RESULTS: A total of 332 patients were included. Pemphigus vulgaris was diagnosed in 82.6% of patients, pemphigus erythematosus in 10.2%, pemphigus foliaceus in 2.4%, and other pemphigus subtypes in 1.8% (including paraneoplastic pemphigus in 1.2%). A female predominance was observed in all pemphigus subtypes except pemphigus foliaceus. The mean (± standard deviation) age at disease onset was 52,1 ± 15,3 years. The peak age of onset occurred in the 35- to 39-year age group for men and the 60- to 64-year age group for women. A diagnostic delay of one year or more after disease onset was observed in 31.8% of patients. The diagnosis was confirmed by histopathological examination in 84.2% of patients (with immunofluorescence methods in 41.3%) and by enzyme-linked immunosorbent assay in 15.8%. Lesion-related pain was reported by 76.3% of patients (including severe pain in 21.5%), and pruritus was reported by 60.6% (including severe pruritus in 9.9%). Infectious complications were observed in 63.5% of patients. Comorbidities included hypertension (34.0%), chronic gastritis (19.3%), coronary artery disease (10.7%), diabetes mellitus (10.2%), thyroid disorders (9.9%), and chronic pancreatitis (8.4%). A history of malignancy was present in 6,4% of patients with non-paraneoplastic pemphigus. CONCLUSION: Pemphigus vulgaris and pemphigus erythematosus are the most common pemphigus subtypes in the Russian Federation. Men tend to experience an earlier age at disease onset. Further research is needed to investigate the causes of diagnostic delays in pemphigus and the underdiagnosis of paraneoplastic pemphigus.
- Open Access
- 25 November 2025
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 101 (5) , 9-21
Key indicators of resources and performance of medical organizations providing medical care in the field of dermatovenereology. Incidence of sexually transmitted infections, diseases of the skin and subcutaneous tissue in the Russian Federation in 2022–2024
Analysis of main indicators of dermatovenereology service of the Russian Federation in 2022–2024 is presented in the paper, including the following: the number of specialized medical organizations and departments, provision of the population of the Russian Federation with dermatovenereologists, dermatovenereologic beds, performance bed rates of dermatovenereologic 24-hour and day hospitals. The incidence of sexually transmitted infections in the entire population of the Russian Federation is presented: the incidence of various forms of syphilis, gonococcal infection, trichomoniasis, chlamydial infection, anogenital herpes viral infection and anogenital venereal warts; the contribution of foreign citizens to syphilis incidence is estimated. The prevalence and incidence rates of skin and subcutaneous tissue diseases by class, atopic dermatitis, psoriasis, contact dermatitis, other dermatitis (eczema), localized scleroderma, discoid lupus erythematosus. for the entire population of the Russian Federation are described.
- 25 November 2025
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 101 (5) , 9-21
Open AccessKey indicators of resources and performance of medical organizations providing medical care in the field of dermatovenereology. Incidence of sexually transmitted infections, diseases of the skin and subcutaneous tissue in the Russian Federation in 2022–2024
Analysis of main indicators of dermatovenereology service of the Russian Federation in 2022–2024 is presented in the paper, including the following: the number of specialized medical organizations and departments, provision of the population of the Russian Federation with dermatovenereologists, dermatovenereologic beds, performance bed rates of dermatovenereologic 24-hour and day hospitals. The incidence of sexually transmitted infections in the entire population of the Russian Federation is presented: the incidence of various forms of syphilis, gonococcal infection, trichomoniasis, chlamydial infection, anogenital herpes viral infection and anogenital venereal warts; the contribution of foreign citizens to syphilis incidence is estimated. The prevalence and incidence rates of skin and subcutaneous tissue diseases by class, atopic dermatitis, psoriasis, contact dermatitis, other dermatitis (eczema), localized scleroderma, discoid lupus erythematosus. for the entire population of the Russian Federation are described.
- Open Access
- 10 June 2025
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 101 (2) , 6-22
Gonorrhea in the Russian Federation: incidence, active case detection and laboratory diagnostics
Background. Gonorrhea is a possible cause of pelvic inflammatory complications, reproductive health disorders and adverse pregnancy outcomes. The problem of gonococcal antimicrobial resistance remains actual. Aims. Analysis of incidence, circumstances of case detection, and methods of laboratory examination for gonococcal infection used in the Russian Federation. Methods. Analysis of state federal statistical surveillance data for 2011–2024. Results. In 2011–2019, the incidence of gonorrhea decreased fivefold, the incidence of total STI — by 2.5 times. In 2020, the incidence of gonorrhea decreased by 13%, STI — 25%. After gonorrhea incidence increase in 2021 and 2022, it was reduced by 4% in 2023, by 15% in 2024. During COVID-19 pandemic, there was a decrease of proportion of patients detected in hospitals (from 1.6% in 2019 to 0.8% in 2020–2024); at medical examinations (from 3.0% in 2019 to 1.7% in 2023); and actively by dermatovenereologists (from 16.2% in 2019 to 12.4% in 2023). In 2019–2024, the proportion of cases confirmed by molecular-biological laboratory examination increased from 27 to 57%. In 2024, molecular-biological, microbiological or both methods were not used to diagnose gonococcal infection in state medical organizations respectively of 13, 42 and 5 constituent entities of the Russian Federation. Conclusion. The distinctive features of gonorrhea incidence dynamics during COVID-19 pandemic are lack of acceleration in decline rate in 2020, and incidence increase in 2021 and 2022, due to an increase in the number of cases among Russian citizens. Against the background of a resumption of gonorrhea incidence decrease in 2023 and 2024, there is no recovery of active case detection measures. The access to highly sensitive laboratory methods in medical organizations of state healthcare system of a number of constituent entities of the Russian Federation is not ensured.
- 10 June 2025
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 101 (2) , 6-22
Open AccessGonorrhea in the Russian Federation: incidence, active case detection and laboratory diagnostics
Background. Gonorrhea is a possible cause of pelvic inflammatory complications, reproductive health disorders and adverse pregnancy outcomes. The problem of gonococcal antimicrobial resistance remains actual. Aims. Analysis of incidence, circumstances of case detection, and methods of laboratory examination for gonococcal infection used in the Russian Federation. Methods. Analysis of state federal statistical surveillance data for 2011–2024. Results. In 2011–2019, the incidence of gonorrhea decreased fivefold, the incidence of total STI — by 2.5 times. In 2020, the incidence of gonorrhea decreased by 13%, STI — 25%. After gonorrhea incidence increase in 2021 and 2022, it was reduced by 4% in 2023, by 15% in 2024. During COVID-19 pandemic, there was a decrease of proportion of patients detected in hospitals (from 1.6% in 2019 to 0.8% in 2020–2024); at medical examinations (from 3.0% in 2019 to 1.7% in 2023); and actively by dermatovenereologists (from 16.2% in 2019 to 12.4% in 2023). In 2019–2024, the proportion of cases confirmed by molecular-biological laboratory examination increased from 27 to 57%. In 2024, molecular-biological, microbiological or both methods were not used to diagnose gonococcal infection in state medical organizations respectively of 13, 42 and 5 constituent entities of the Russian Federation. Conclusion. The distinctive features of gonorrhea incidence dynamics during COVID-19 pandemic are lack of acceleration in decline rate in 2020, and incidence increase in 2021 and 2022, due to an increase in the number of cases among Russian citizens. Against the background of a resumption of gonorrhea incidence decrease in 2023 and 2024, there is no recovery of active case detection measures. The access to highly sensitive laboratory methods in medical organizations of state healthcare system of a number of constituent entities of the Russian Federation is not ensured.
- Open Access
- 26 August 2024
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 100 (4) , 9-24
Dermatovenereology in the Russian Federation: results of 2023
The article presents information on dynamics of dermatovenerological service resources, indicators of the population of the Russian Federation provision with dermatovenerologists and dermatovenerological beds, main performance rates and results of dermatovenereological medical care providing in outpatient, inpatient and day hospital conditions for the period 2019–2023. The dynamics of sexually transmitted infections (syphilis, gonococcal infection, trichomoniasis, chlamydial infection, anogenital herpetic viral infection and anogenital venereal warts) incidence in the Russian Federation, as well as contribution of foreign citizens to the syphilis incidence rates are analyzed. The dynamics of prevalence and incidence rates of diseases of the skin and subcutaneous tissue in the Russian Federation in 2019–2023, as well as dynamics of prevalence and incidence of atopic dermatitis, psoriasis, contact dermatitis, localized scleroderma, discoid lupus erythematosus among children aged 0–17 years and adults 18 years and older are presented.
- 26 August 2024
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 100 (4) , 9-24
Open AccessDermatovenereology in the Russian Federation: results of 2023
The article presents information on dynamics of dermatovenerological service resources, indicators of the population of the Russian Federation provision with dermatovenerologists and dermatovenerological beds, main performance rates and results of dermatovenereological medical care providing in outpatient, inpatient and day hospital conditions for the period 2019–2023. The dynamics of sexually transmitted infections (syphilis, gonococcal infection, trichomoniasis, chlamydial infection, anogenital herpetic viral infection and anogenital venereal warts) incidence in the Russian Federation, as well as contribution of foreign citizens to the syphilis incidence rates are analyzed. The dynamics of prevalence and incidence rates of diseases of the skin and subcutaneous tissue in the Russian Federation in 2019–2023, as well as dynamics of prevalence and incidence of atopic dermatitis, psoriasis, contact dermatitis, localized scleroderma, discoid lupus erythematosus among children aged 0–17 years and adults 18 years and older are presented.
- Open Access
- 16 October 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (4) , 96-102
Predictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)
Background. Psoriatic arthritis risk prediction and early detection in patients with psoriasis may help prevent irreversible musculoskeletal changes and improve patients outcomes. Aims. To develop and validate predictive model for psoriatic arthritis risk assessment and classification for patients with moderate-to-severe psoriasis based on demographic and clinical characteristics. Materials and methods. Data of psoriasis patient registry of Russian Society of Dermatovenereologists and Cosmetologists was analyzed. Significant differences between independent variables of interest among patients with and without psoriatic arthritis were determined by means of 2-test or MannWitney test. Predictive models were developed stepwise by means of logistic regression analysis. Independent variables of low significance were excluded from the model. Regression coefficients were considered significant if p 0.05. The optimal cut-off value was derived from ROC-analysis. The model performance was evaluated by calculation of AUC, sensitivity and specificity on training and test datasets. Finally, adjusted regression coefficients, AUC, sensitivity and specificity were derived for pooled data. Results. Training sample included 3245 patients with psoriasis, 920 of them had diagnosis of psoriatic arthritis. The final predictive model included five significant predictors: psoriasis duration, medical history of psoriatic erythroderma, family history of psoriatic arthritis, arterial hypertension, and fatty liver. All regression coefficients were highly significant (p 0.001). The AUC of prediction model adjusted on pooled data was 0,7473, sensitivity 70%, specificity 66% for cut-off value 0.212. Conclusions. Developed predictive model for risk assessment of psoriatic arthritis may contribute to its earlier detection in patients with psoriasis taking into account the degree of influence of significant predictors. The proposed classification may be used to discriminate patients at higher risk of psoriatic arthritis.
- 16 October 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (4) , 96-102
Open AccessPredictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)
Background. Psoriatic arthritis risk prediction and early detection in patients with psoriasis may help prevent irreversible musculoskeletal changes and improve patients outcomes. Aims. To develop and validate predictive model for psoriatic arthritis risk assessment and classification for patients with moderate-to-severe psoriasis based on demographic and clinical characteristics. Materials and methods. Data of psoriasis patient registry of Russian Society of Dermatovenereologists and Cosmetologists was analyzed. Significant differences between independent variables of interest among patients with and without psoriatic arthritis were determined by means of 2-test or MannWitney test. Predictive models were developed stepwise by means of logistic regression analysis. Independent variables of low significance were excluded from the model. Regression coefficients were considered significant if p 0.05. The optimal cut-off value was derived from ROC-analysis. The model performance was evaluated by calculation of AUC, sensitivity and specificity on training and test datasets. Finally, adjusted regression coefficients, AUC, sensitivity and specificity were derived for pooled data. Results. Training sample included 3245 patients with psoriasis, 920 of them had diagnosis of psoriatic arthritis. The final predictive model included five significant predictors: psoriasis duration, medical history of psoriatic erythroderma, family history of psoriatic arthritis, arterial hypertension, and fatty liver. All regression coefficients were highly significant (p 0.001). The AUC of prediction model adjusted on pooled data was 0,7473, sensitivity 70%, specificity 66% for cut-off value 0.212. Conclusions. Developed predictive model for risk assessment of psoriatic arthritis may contribute to its earlier detection in patients with psoriasis taking into account the degree of influence of significant predictors. The proposed classification may be used to discriminate patients at higher risk of psoriatic arthritis.
- Open Access
- 16 October 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (4) , 18-40
Resources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022
The paper describes changes in resources and performance of medical organizations providing medical care in the field of dermatovenereology in 20162022. The dynamics of the main rates of the service was analyzed, and the rates achieved in 2022 were compared with those before the pandemic of a new coronavirus infection. The rates of the provision of the population of the Russian Federation with dermatovenereologists, 24-hour and daytime dermatovenereological beds are presented. The analysis of the volumes of dermatovenereologic medical care dynamics provided in outpatient, inpatient and day hospital conditions was carried out. The dynamics of incidence of sexually transmitted infections is described, contribution of syphilis cases among foreign citizens to syphilis rates is presented. The changes in prevalence and incidence rates of diseases of the skin and subcutaneous tissue, as well as atopic dermatitis, psoriasis, contact dermatitis, other dermatitis, localized scleroderma, and discoid lupus erythematosus are analyzed.
- 16 October 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (4) , 18-40
Open AccessResources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022
The paper describes changes in resources and performance of medical organizations providing medical care in the field of dermatovenereology in 20162022. The dynamics of the main rates of the service was analyzed, and the rates achieved in 2022 were compared with those before the pandemic of a new coronavirus infection. The rates of the provision of the population of the Russian Federation with dermatovenereologists, 24-hour and daytime dermatovenereological beds are presented. The analysis of the volumes of dermatovenereologic medical care dynamics provided in outpatient, inpatient and day hospital conditions was carried out. The dynamics of incidence of sexually transmitted infections is described, contribution of syphilis cases among foreign citizens to syphilis rates is presented. The changes in prevalence and incidence rates of diseases of the skin and subcutaneous tissue, as well as atopic dermatitis, psoriasis, contact dermatitis, other dermatitis, localized scleroderma, and discoid lupus erythematosus are analyzed.
- 8 September 2023
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 45 (3)
Prediction of period till psoriatic arthritis onset in patients with psoriasis
Objective. To test the previously developed prediction model on another sample of patients and obtain the refined coefficients of formulas and graphs on pooled data in development of methodology for predicting the period till psoriatic arthritis onset in patients with moderate and severe psoriasis. Material and methods. We analyzed the data of psoriasis patient registry of the Russian Society of Dermatovenereologists and Cosmetologists. The main sample consisted of patients included in the registry between September 24, 2018 and November 12, 2021 (n=760). The sample for model applicability testing consisted of patients included in the registry between November 13, 2021 and December 19, 2022 (n=398). The quantile lines were obtained on the main sample using polynomial quantile regression analysis. We analyzed applicability of these results to external data via comparing 95% confidence intervals of quantiles of periods till psoriatic arthritis onset, calculated on the new data, and quantile regression lines obtained on the main sample. The formulas of quantile lines for the pooled data were derived by polynomial quantile regression analysis. Results. Quantile regression lines obtained on the main sample were in good agreement with 95% confidence intervals of quantiles based on the new data. This model was applicable to external data. After combining main and new data, we obtained the adjusted coefficients for the formulas describing quantile lines. Conclusion. Applicability of prediction model for calculating the 95%, 75%, 50% and 25% quantiles of period till psoriatic arthritis onset to external data was confirmed. Refined predictive formulas can be used in clinical practice to assess the likely period till psoriatic arthritis onset in patients with moderate and severe psoriasis.
- 8 September 2023
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 45 (3)
Prediction of period till psoriatic arthritis onset in patients with psoriasis
Objective. To test the previously developed prediction model on another sample of patients and obtain the refined coefficients of formulas and graphs on pooled data in development of methodology for predicting the period till psoriatic arthritis onset in patients with moderate and severe psoriasis. Material and methods. We analyzed the data of psoriasis patient registry of the Russian Society of Dermatovenereologists and Cosmetologists. The main sample consisted of patients included in the registry between September 24, 2018 and November 12, 2021 (n=760). The sample for model applicability testing consisted of patients included in the registry between November 13, 2021 and December 19, 2022 (n=398). The quantile lines were obtained on the main sample using polynomial quantile regression analysis. We analyzed applicability of these results to external data via comparing 95% confidence intervals of quantiles of periods till psoriatic arthritis onset, calculated on the new data, and quantile regression lines obtained on the main sample. The formulas of quantile lines for the pooled data were derived by polynomial quantile regression analysis. Results. Quantile regression lines obtained on the main sample were in good agreement with 95% confidence intervals of quantiles based on the new data. This model was applicable to external data. After combining main and new data, we obtained the adjusted coefficients for the formulas describing quantile lines. Conclusion. Applicability of prediction model for calculating the 95%, 75%, 50% and 25% quantiles of period till psoriatic arthritis onset to external data was confirmed. Refined predictive formulas can be used in clinical practice to assess the likely period till psoriatic arthritis onset in patients with moderate and severe psoriasis.
- 16 March 2023
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 45 (1)
Quantile regression analysis in prediction of time till psoriatic arthritis onset in patients with psoriasis
Objective. To assess the possibilities of polynomial quantile regression analysis in prediction of time till psoriatic arthritis onset depending on age of manifestation of moderate-to-severe psoriasis. Material and methods. We analyzed the data of psoriasis patient registry of the Russian Society of Dermatovenereologists and Cosmetologists. Distribution normality was tested using the Shapiro—Wilk test. Data heteroscedasticity was assessed using scatter diagrams. In accordance with quantile definition, we determined 95%, 75%, 50% and 25% quantiles of time to development of psoriatic arthritis. The bootstrap method was used to obtain 95% confidence intervals (CI) for quantile values. Lines of 95%, 75%, 50% and 25% quantiles were obtained by polynomial quantile regression. To test the assumption about admissibility and expediency of polynomial quantile regression, we compared 95% CI and appropriate quantile regression lines. Results. There were 760 patients. We found no normal distribution in all ranges of age of psoriasis onset. The absence of homoscedasticity and normal distribution of data ruled out parametric statistical analysis and linear regression analysis. Comparing the positions of 95% CI of the calculated subrange values of 95%, 75%, 50% and 25% quantiles for time till psoriatic arthritis onset and quantile regression lines for the same quantiles, we found that parabolic quantile regression data are in good agreement with calculation of subrange quantiles. Conclusion. Polynomial quantile regression is advisable to predict time till psoriatic arthritis onset depending on age of onset of moderate-to-severe psoriasis.
- 16 March 2023
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 45 (1)
Quantile regression analysis in prediction of time till psoriatic arthritis onset in patients with psoriasis
Objective. To assess the possibilities of polynomial quantile regression analysis in prediction of time till psoriatic arthritis onset depending on age of manifestation of moderate-to-severe psoriasis. Material and methods. We analyzed the data of psoriasis patient registry of the Russian Society of Dermatovenereologists and Cosmetologists. Distribution normality was tested using the Shapiro—Wilk test. Data heteroscedasticity was assessed using scatter diagrams. In accordance with quantile definition, we determined 95%, 75%, 50% and 25% quantiles of time to development of psoriatic arthritis. The bootstrap method was used to obtain 95% confidence intervals (CI) for quantile values. Lines of 95%, 75%, 50% and 25% quantiles were obtained by polynomial quantile regression. To test the assumption about admissibility and expediency of polynomial quantile regression, we compared 95% CI and appropriate quantile regression lines. Results. There were 760 patients. We found no normal distribution in all ranges of age of psoriasis onset. The absence of homoscedasticity and normal distribution of data ruled out parametric statistical analysis and linear regression analysis. Comparing the positions of 95% CI of the calculated subrange values of 95%, 75%, 50% and 25% quantiles for time till psoriatic arthritis onset and quantile regression lines for the same quantiles, we found that parabolic quantile regression data are in good agreement with calculation of subrange quantiles. Conclusion. Polynomial quantile regression is advisable to predict time till psoriatic arthritis onset depending on age of onset of moderate-to-severe psoriasis.
- Open Access
- 26 February 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (1) , 48-54
Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
Background. Early detection of psoriatic arthritis in patients with psoriasis remains an unmet medical need. Early diagnosis and treatment initiation in patients with psoriatic arthritis decreases the risk of adverse patient outcomes and improves patients quality of life. Aims. To describe a period between psoriasis and psoriatic arthritis onset and a period between psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis. Materials and methods. Analysis of data from the psoriasis patient registry. Patients aged 18 years and older with an established diagnosis of psoriasis and psoriatic arthritis were included in the analysis. Noninclusion criteria: no data on psoriasis and/or psoriatic arthritis onset (for the period between psoriasis and psoriatic arthritis onset description); no data on psoriatic arthritis onset and/or diagnosis (for the period between psoriatic arthritis onset and diagnosis description). Results. Sample size for the descriptive characteristic of period between psoriasis and psoriatic arthritis onset was 891 patients; sample size for the descriptive characteristic of period between psoriatic arthritis onset and diagnosis was 849 patients. Psoriatic arthritis onset preceeded cutaneous manifestation of psoriasis in 2.5% of patients. Concurrent onset of cutaneous psoriasis and psoriatic arthritis (within one year) had 10.7% of patients. In 86.8% of patients, cutaneous manifestation of psoriasis preceded manifestation of psoriatic arthritis. Exclusively of patients with psoriatic arthritis developed before or concurrently with cutaneous manifestation of psoriasis, the mean duration of period between psoriasis and psoriatic arthritis onset was 13.7 10.3 years, the median [IQR] 12 [619] years. In 24% of patients psoriatic arthritis was diagnosed 1 year and more after its onset. The mean (SD) period from signs and|or symptoms onset till psoriatic arthritis diagnosis was 3.9 5.0 years; median [IQR] was 2 [14.5] years. Conclusions. A diagnostic delay in 24% Russian patients with psoriatic arthritis is one year or more. In this subgroup of patients the mean delay in diagnosis of psoriatic arthritis is about 4 years.
- 26 February 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (1) , 48-54
Open AccessPeriods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
Background. Early detection of psoriatic arthritis in patients with psoriasis remains an unmet medical need. Early diagnosis and treatment initiation in patients with psoriatic arthritis decreases the risk of adverse patient outcomes and improves patients quality of life. Aims. To describe a period between psoriasis and psoriatic arthritis onset and a period between psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis. Materials and methods. Analysis of data from the psoriasis patient registry. Patients aged 18 years and older with an established diagnosis of psoriasis and psoriatic arthritis were included in the analysis. Noninclusion criteria: no data on psoriasis and/or psoriatic arthritis onset (for the period between psoriasis and psoriatic arthritis onset description); no data on psoriatic arthritis onset and/or diagnosis (for the period between psoriatic arthritis onset and diagnosis description). Results. Sample size for the descriptive characteristic of period between psoriasis and psoriatic arthritis onset was 891 patients; sample size for the descriptive characteristic of period between psoriatic arthritis onset and diagnosis was 849 patients. Psoriatic arthritis onset preceeded cutaneous manifestation of psoriasis in 2.5% of patients. Concurrent onset of cutaneous psoriasis and psoriatic arthritis (within one year) had 10.7% of patients. In 86.8% of patients, cutaneous manifestation of psoriasis preceded manifestation of psoriatic arthritis. Exclusively of patients with psoriatic arthritis developed before or concurrently with cutaneous manifestation of psoriasis, the mean duration of period between psoriasis and psoriatic arthritis onset was 13.7 10.3 years, the median [IQR] 12 [619] years. In 24% of patients psoriatic arthritis was diagnosed 1 year and more after its onset. The mean (SD) period from signs and|or symptoms onset till psoriatic arthritis diagnosis was 3.9 5.0 years; median [IQR] was 2 [14.5] years. Conclusions. A diagnostic delay in 24% Russian patients with psoriatic arthritis is one year or more. In this subgroup of patients the mean delay in diagnosis of psoriatic arthritis is about 4 years.
- Open Access
- 27 January 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 98 (6) , 73-80
Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
Background. Psoriatic erythroderma is rare and one of the most severe forms of psoriasis characterized by involvement of 8090% of body surface area. Aims. To compare clinical and demographic characteristics of patients with psoriasis, depending on presence of psoriatic erythroderma in medical history; to assess the association between psoriatic arthritis and a history of psoriatic erythroderma. Materials and methods. Patients aged 18 years and older with a duration of psoriasis of 10 years, from the psoriasis patients registry were included. Comparison of continuous quantitative variables was performed using t-test or MannWhitney U-test. The 2 test or Fisher's exact test was used to compare qualitative binary variables. The odds ratio of psoriatic arthritis in patients with and without a history of psoriatic erythroderma was calculated, unadjusted and adjusted for other independent variables. Results. The number of patients included in the analysis was 1,870. A history of psoriatic erythroderma (PE) had 227 (12.1%) of them. There were no significant differences in patient age at inclusion to the registry (47.1 13.1 years vs. 47.7 13.3 years), and prevalence of PE among men and women (12.6% vs. 11. 4%). Higher prevalence of arterial hypertension (47.9% vs 32.7%), angina pectoris (6.4% vs. 1.9%), myocardial infarction (3.2% vs. 1.0%), biliary dyskynesia (14.3% vs. 3.9%), fatty liver (12.2% vs. 7.7%), cholelithiasis (8.6% vs. 3.6%), and toxic liver disease (2.2% vs. 0.5%) among patients with vs without history of PE was found. Psoriatic arthritis was diagnosed in 67.0% patients with a history of psoriatic erythroderma. The odds of having psoriatic arthritis in patients with a history of psoriatic erythroderma were 4 times higher than in patients without erythroderma: 4.043 [2.9755.493]. When adjusted for sex, age, duration of psoriasis, and body mass index, the odds ratio and statistical significance were maintained: 4.064 [2.9395.619]. Conclusions. Compared to patients without PE those with a history of psoriatic erythroderma have a greater comorbidity burden: a higher prevalence of cardiovascular diseases, diseases of the liver and biliary tract. A significant association between psoriatic arthritis and a history of PE was established.
- 27 January 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 98 (6) , 73-80
Open AccessPsoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
Background. Psoriatic erythroderma is rare and one of the most severe forms of psoriasis characterized by involvement of 8090% of body surface area. Aims. To compare clinical and demographic characteristics of patients with psoriasis, depending on presence of psoriatic erythroderma in medical history; to assess the association between psoriatic arthritis and a history of psoriatic erythroderma. Materials and methods. Patients aged 18 years and older with a duration of psoriasis of 10 years, from the psoriasis patients registry were included. Comparison of continuous quantitative variables was performed using t-test or MannWhitney U-test. The 2 test or Fisher's exact test was used to compare qualitative binary variables. The odds ratio of psoriatic arthritis in patients with and without a history of psoriatic erythroderma was calculated, unadjusted and adjusted for other independent variables. Results. The number of patients included in the analysis was 1,870. A history of psoriatic erythroderma (PE) had 227 (12.1%) of them. There were no significant differences in patient age at inclusion to the registry (47.1 13.1 years vs. 47.7 13.3 years), and prevalence of PE among men and women (12.6% vs. 11. 4%). Higher prevalence of arterial hypertension (47.9% vs 32.7%), angina pectoris (6.4% vs. 1.9%), myocardial infarction (3.2% vs. 1.0%), biliary dyskynesia (14.3% vs. 3.9%), fatty liver (12.2% vs. 7.7%), cholelithiasis (8.6% vs. 3.6%), and toxic liver disease (2.2% vs. 0.5%) among patients with vs without history of PE was found. Psoriatic arthritis was diagnosed in 67.0% patients with a history of psoriatic erythroderma. The odds of having psoriatic arthritis in patients with a history of psoriatic erythroderma were 4 times higher than in patients without erythroderma: 4.043 [2.9755.493]. When adjusted for sex, age, duration of psoriasis, and body mass index, the odds ratio and statistical significance were maintained: 4.064 [2.9395.619]. Conclusions. Compared to patients without PE those with a history of psoriatic erythroderma have a greater comorbidity burden: a higher prevalence of cardiovascular diseases, diseases of the liver and biliary tract. A significant association between psoriatic arthritis and a history of PE was established.